Skin cancer and immunosuppression.

Area of Science:

• Nephrology
• Dermatology
• Oncology

Background:

• Immunosuppressive therapy is crucial for kidney transplant recipients to prevent organ rejection.
• Long-term immunosuppression is associated with an increased risk of various cancers, including lymphoreticular malignancies.
• The specific impact of immunosuppression on non-lymphoid skin cancers in kidney transplant patients requires further elucidation.

Purpose of the Study:

• To investigate the incidence and characteristics of malignant skin tumors in kidney-allograft recipients.
• To assess the relationship between immunosuppressive treatment and the development of specific skin cancers.
• To understand the progression and recurrence patterns of skin cancers under immunosuppression.

Main Methods:

• Retrospective analysis of 51 kidney-allograft recipients.
• Monitoring for the development of skin tumors post-transplantation (4-45 months).
• Documentation of tumor type, number, and recurrence.

Main Results:

• 7 out of 51 (14%) recipients developed 19 malignant skin tumors.
• Squamous-cell carcinoma was a prominent diagnosis, with accelerated progression from hyperkeratosis observed.
• Increased frequency and early recurrence of keratoacanthoma were noted.
• Multiple skin cancers occurred in some patients.

Conclusions:

• Kidney transplant recipients on immunosuppression have a significantly elevated risk of developing malignant skin tumors, particularly squamous-cell carcinoma.
• Immunosuppressive regimens may promote the rapid evolution and recurrence of skin cancers.
• Close dermatological surveillance is essential for early detection and management of skin malignancies in this patient population.